Menu Close


BCCC-CURE/ASRC Half Day Scientific Symposium "Diverse Approaches to Cancer Therapy"

March 25, 2022

  • Targeted Perturbation of Epigenetic Landscape for Solid Tumor Therapy, Adegboyega K. Oyelere, Ph.D., Georgia Institute of Technology
  • Computer-aided molecular design: from virtual screening to de novo generation with models of chemical reactivity, Connor Coley, Ph.D., The Massachusetts Institute of Technology
  • HIF-2alpha inhibitors: Role of basic science in starting path to clinical use, Kevin H. Gardner, Ph.D., Advanced Science Research Center – City University of New York
  • HIF2 inhibitors Clinical Development and trials, Toni Choueiri, M.D., Dana-Faber Cancer Institute Harvard University
  • Student Opportunities:
    • BCCC-CURE Garil Research Internships
    • Mt. Sinai School of Medicine Lay Health Advocate Training
  • Panel Discussion

Please register for this virtual here.



View full calendar